Healthcare -
Biotechnology - NASDAQ - US
$ 46.88
1.94 %
$ 2.02 B
Market Cap
-16.8
P/E
SLNO - OPERATING EXPENSES
Operating Expenses SLNO - Soleno Therapeutics, Inc.
41.4 M
LAST VALUE
13.26%
2 YEAR CAGR
24.68%
5 YEAR CAGR
26.82%
10 YEAR CAGR